Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring!
- PMID: 30606485
- DOI: 10.1016/j.jchf.2018.11.016
Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring!
Keywords: chronic kidney disease; heart failure with preserved ejection fraction; hyperkalemia; spironolactone.
Comment on
-
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.JACC Heart Fail. 2019 Jan;7(1):25-32. doi: 10.1016/j.jchf.2018.10.017. JACC Heart Fail. 2019. PMID: 30606484
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
